Show simple item record

dc.contributor.authorCasal Guisande, Manuel 
dc.contributor.authorÁlvarez Pazó, Antía
dc.contributor.authorCerqueiro Pequeño, Jorge 
dc.contributor.authorBouza Rodriguez, Jose Benito 
dc.contributor.authorPelaez Lourido, Gustavo Carlos 
dc.contributor.authorComesaña Campos, Alberto 
dc.date.accessioned2023-04-12T07:54:36Z
dc.date.available2023-04-12T07:54:36Z
dc.date.issued2023-03-10
dc.identifier.citationCancers, 15(6): 1711 (2023)spa
dc.identifier.issn20726694
dc.identifier.urihttp://hdl.handle.net/11093/4690
dc.description.abstractBreast cancer is the most frequently diagnosed tumor pathology on a global scale, being the leading cause of mortality in women. In light of this problem, screening programs have been implemented on the population at risk in the form of mammograms, starting in the 20th century. This has considerably reduced the associated deaths, as well as improved the prognosis of the patients who suffer from this disease. In spite of this, the evaluation of mammograms is not without certain variability and depends, to a large extent, on the experience and training of the medical team carrying out the assessment. With the aim of supporting the evaluation process of mammogram images and improving the diagnosis process, this work presents the design, development and proof of concept of a novel intelligent clinical decision support system, grounded on two predictive approaches that work concurrently. The first of them applies a series of expert systems based on fuzzy inferential engines, geared towards the treatment of the characteristics associated with the main findings present in mammograms. This allows the determination of a series of risk indicators, the Symbolic Risks, related to the risk of developing breast cancer according to the different findings. The second one implements a classification machine learning algorithm, which using data related to mammography findings as well as general patient information determines another metric, the Statistical Risk, also linked to the risk of developing breast cancer. These risk indicators are then combined, resulting in a new indicator, the Global Risk. This could then be corrected using a weighting factor according to the BI-RADS category, allocated to each patient by the medical team in charge. Thus, the Corrected Global Risk is obtained, which after interpretation can be used to establish the patient’s status as well as generate personalized recommendations. The proof of concept and software implementation of the system were carried out using a data set with 130 patients from a database from the School of Medicine and Public Health of the University of Wisconsin-Madison. The results obtained were encouraging, highlighting the potential use of the application, albeit pending intensive clinical validation in real environments. Moreover, its possible integration in hospital computer systems is expected to improve diagnostic processes as well as patient prognosis.en
dc.description.sponsorshipXunta de Galicia | Ref. ED481A-2020/038spa
dc.language.isoengspa
dc.publisherCancersspa
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleProposal and definition of an intelligent clinical decision support system applied to the screening and early diagnosis of breast canceren
dc.typearticlespa
dc.rights.accessRightsopenAccessspa
dc.identifier.doi10.3390/cancers15061711
dc.identifier.editorhttps://www.mdpi.com/2072-6694/15/6/1711spa
dc.publisher.departamentoDeseño na enxeñaríaspa
dc.publisher.grupoinvestigacionGrupo de Enxeñería de Deseño e Fabricación (GEDEFA)spa
dc.publisher.grupoinvestigacionGED (Grupo de Enxeñería e Deseño)spa
dc.subject.unesco3207.03 Carcinogénesisspa
dc.subject.unesco1203.20 Sistemas de Control Medicospa
dc.subject.unesco1203.04 Inteligencia Artificialspa
dc.date.updated2023-04-12T07:52:28Z
dc.computerCitationpub_title=Cancers|volume=15|journal_number=6|start_pag=1711|end_pag=spa


Files in this item

[PDF]

    Show simple item record

    Attribution 4.0 International
    Except where otherwise noted, this item's license is described as Attribution 4.0 International